Neurotrope, Inc.

The end of 2024 brought near-term cash shortfalls into focus at several biopharmaceutical companies, while others completed their assessments of potential alternatives to shutting their doors as capit

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker . Roche Pays Vividion $135m Up Front In

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang

GE Healthcare and Vanderbilt University Medical Center are working together to combine immuno-oncology with precision medicine through a five-year collaboration unveiled Jan. 6, to determine which